Erlotinib-Heptamethine Cyanine Dye Conjugate (Shenyang Pharmaceutical University)

N/A

Report date: 2026/05/09 20:00:18

NME

Base Information

Drug NameErlotinib-Heptamethine Cyanine Dye Conjugate (Shenyang Pharmaceutical University)

Drug Alias NameEpidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor Conjugated with Heptamethine Cyanine Dye (Shenyang Pharmaceutical)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesShenyang Pharmaceutical University

China Registration ClassN/A

Develop Information

Active CompaniesShenyang Pharmaceutical University

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A